We are well on track for the delivery of the last major milestones of the “Growth for Impact 2024” strategic plan in 2024.
We reached €74 million of cumulated run-rate annual EBITDA synergies at end of 2023, above our €70 million interim target.
The migration of Italian derivatives trading to Optiq® in Q1 2024 and the expansion of Euronext Clearing to Euronext listed financial and commodities derivatives by Q3 2024 will significantly contribute to reaching the targeted €115 million synergies by end of 2024.